Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Central Nervous System Neoplasms 6Astrocytoma 5Oligodendroglioma 4Optic Nerve Glioma 3Medulloblastoma 3Gliosarcoma 3Glioblastoma 3Familial ependymoma 3Choroid Plexus Neoplasms 3Lymphoma, T-Cell, Cutaneous 2Brain Neoplasms 2Wilms Tumor 1Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Teratoma 1Sezary Syndrome 1Sarcoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mycosis Fungoides 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Glioma 1Ependymoma 1

Interventions

Magnetic Resonance Spectroscopy 9X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Temozolomide 4Carmustine 4Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vemurafenib 2Surgical Procedures, Operative 2Radiotherapy 2Lapatinib 2LY3023414 2Filgrastim 2Cyclophosphamide 2Congresses as Topic 2Cisplatin 2Bevacizumab 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2veliparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Ependymoma × O(6)-benzylguanine × Clear all
NCT00004892 2009-02-09

O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡